Waters Co. (NYSE:WAT) Given Average Rating of “Hold” by Brokerages
Waters Co. (NYSE:WAT) has received a consensus recommendation of “Hold” from the fifteen analysts that are covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $210.54.
WAT has been the subject of several research reports. Zacks Investment Research upgraded Waters from a “sell” rating to a “hold” rating and set a $217.00 target price for the company in a research report on Wednesday, May 22nd. Wolfe Research initiated coverage on Waters in a research report on Thursday, May 30th. They issued an “underperform” rating for the company. Barclays decreased their target price on Waters from $218.00 to $210.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 24th. Cleveland Research lowered Waters from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 12th. Finally, Robert W. Baird decreased their target price on Waters from $211.00 to $209.00 and set a “neutral” rating for the company in a research report on Wednesday, April 24th.
Large investors have recently added to or reduced their stakes in the stock. Compagnie Lombard Odier SCmA acquired a new position in Waters during the 2nd quarter valued at approximately $37,000. Massey Quick Simon & CO. LLC acquired a new position in Waters during the 1st quarter valued at approximately $43,000. CSat Investment Advisory L.P. boosted its position in Waters by 212.5% during the 2nd quarter. CSat Investment Advisory L.P. now owns 225 shares of the medical instruments supplier’s stock valued at $48,000 after purchasing an additional 153 shares during the period. Private Capital Group LLC boosted its position in Waters by 92.0% during the 2nd quarter. Private Capital Group LLC now owns 288 shares of the medical instruments supplier’s stock valued at $56,000 after purchasing an additional 138 shares during the period. Finally, Financial Gravity Wealth Inc. acquired a new position in Waters during the 1st quarter valued at approximately $63,000. Institutional investors and hedge funds own 96.08% of the company’s stock.
Waters (NYSE:WAT) last issued its earnings results on Tuesday, July 30th. The medical instruments supplier reported $2.14 EPS for the quarter, topping the consensus estimate of $2.11 by $0.03. The company had revenue of $599.20 million during the quarter, compared to analyst estimates of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. The business’s revenue was up .5% on a year-over-year basis. During the same quarter last year, the firm earned $1.95 EPS. Equities analysts expect that Waters will post 9.01 earnings per share for the current year.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Read More: Balanced Fund
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.